Home
Supriya Lifescience Limited
Press Release Dec 09 2024
Business
Dec 9 2024
5 min read

Press Release Dec 09 2024

Supriya Lifescience Limited has informed the Exchange regarding a press release dated December 09, 2024, titled "Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing".

View Attachment